Loading dashboard...
Peptide Assistant
Online
AI can make mistakes. Verify important medical data.
Press Enter to send
G
Medical Engine
Guest Account
AI can make mistakes. Verify important medical data.
Press Enter to send
Medical Engine
Guest Account
Loading dashboard...
The Psychoplastogen Duel. Comparing Glutamatergic vs Serotonergic pathways for Neural Plasticity.
Ketamine primarily targets the NMDA receptor, causing a paradoxical glutamate surge that triggers rapid synaptogenesis. Psilocybin acts on the 5-HT2A serotonin receptor, promoting global neural connectivity and a "reset" of the Default Mode Network (DMN).
Ketamine is purely chemical/biological in its clinical application; the "trip" is often considered a side effect in medical settings.
Psilocybin efficacy is highly correlated with the subjective "mystical experience," requiring extensive integration therapy.
While both compounds promote BDNF and dendritic sprouting, they do so with different "textures." Ketamine is often used to break an acute depressive crisis quickly (within hours), while psilocybin is favored for deep-seated trauma and existential distress where a fundamental shifts in perspective is required.
Typically 6 sessions over 2-3 weeks for a sustained response.
Typically 1 or 2 high-dose sessions with 10+ hours of prep/integration.
"Ketamine is the quick-response team for neural despair; Psilocybin is the architect for deep-seated neural reconstruction. Both are essential tools in the frontier psychoplastogen toolkit."